Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...
Penn and CHOP researchers want to develop urea cycle disorder treatments using CRISPR gene-editing therapy. Get unlimited access to Inquirer.com and The Inquirer App, plus 5 articles each month to ...
The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
Ecuadorian scientists have, for the first time, edited the gene of a fungus that destroys banana plantations. Using an ...
The Daily Galaxy on MSN
From Frankenstein to Reality: Five Experiments Where Science Crossed the Line Into Fiction
When Mary Shelley publishedFrankenstein; or, The Modern Prometheus in 1818, she wasn’t just writing a gothic horror novel—she ...
ANTLER phase 1 data demonstrate efficacy and durability on par with autologous CAR-T cell therapy and safety allows for ...
UniQure stock dropped after the FDA sent feedback on the company's pending treatment for Huntington's disease. Read more on ...
Union Minister of State for Health and Family Welfare, Smt Anupriya Singh Patel recently delivered the keynote address at the 2nd DHR-ICMR Health Research Excellence Summit 2025. Dr V ...
Detailed price information for Caribou Biosciences Inc (CRBU-Q) from The Globe and Mail including charting and trades.
Detailed price information for Caribou Biosciences Inc (CRBU-Q) from The Globe and Mail including charting and trades.
Investigators who designed a base-editing treatment are planning an "umbrella of umbrellas" trial, while others are developing roadmaps to guide personalized treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback